Pharmaceutical leaders are skeptical of claims that AI could cure most diseases within a decade; the US FDA has yet to clear any AI-designed biotech drugs
Featured Podcasts
A quiet investor's $10 billion bet on AI, chips, and defense
Candid conversations with the leaders shaping what's next in AI and the broader tech industry. Hosted by Alex Heath, who has covered Silicon Valley for more than a decade.
Subscribe to Sources.
The company building America's uranium supply from scratch
Stripe cofounder John Collison interviews founders, builders, and leaders over a pint.
Subscribe to Cheeky Pint.
The Difference Between 1% Improvements and 10x Growth | Immad Akhund
Grit explores what it takes to create, build and scale world-class organizations.
Subscribe to Grit.
How a 19-year-old intern built the growth engine behind this $2B AI company | Hector Serrano
Interviews with world-class product leaders and growth experts to uncover actionable advice to help you build, launch, and grow your own product.
Subscribe to Lenny's Podcast.
Copyright of this story solely belongs to www.techmeme.com. To see the full text click HERE
